❭ Research by medical division ❭ Cancer Medicine ❭ Institute for Cancer Research ❭ Dept. of Cancer Genetics ❭ Translational studies on solid tumours [Helland] ❭ Group members ❭ Associated members ❭

Associated members

Sigmund Brabrand

Katarina Puco

Kathinka Slørdahl

Kajsa Johansson

Pitt Niehusmann

Charlotte Helen Melby

Elisa Bjørgo

Stina Stålberg

 
Scroll to top

Home Dept. of Cancer Genetics Translational studies on solid tumours [Helland]

  • Group members
    • Associated members
  • Clinical trials
  • Translational studies
  • Publications
  • News

Recent publications

Garcia-Foncillas J, Bayle A, Arnold D, Avouac B, Awada A, de la Cruz-Merino L, Helland Å, Lassen U, Laurent-Puig P, Normanno N, Rohrberg K, Taieb J, Stenzinger A (2025)
Overcoming barriers to advanced biomolecular technologies that inform treatment of solid tumors: a roadmap to access
Future Oncol, 1-8 (in press)
DOI 10.1080/14796694.2025.2501523, PubMed 40340714

Hektoen HH, Tsuruda KM, Brustugun OT, Neumann K, Andreassen BK (2025)
Real-world comparison of pembrolizumab alone and combined with chemotherapy in metastatic lung adenocarcinoma patients with PD-L1 expression ≥50
ESMO Open, 10 (5), 105073
DOI 10.1016/j.esmoop.2025.105073, PubMed 40305908

Tsuruda KM, Hektoen HH, Aamelfot C, Andreassen BK (2025)
Let's talk about sex: Survival among females and males in a real-world cohort treated with pembrolizumab for non-small cell lung cancer
Int J Cancer (in press)
DOI 10.1002/ijc.35445, PubMed 40298324

More publications

Oslo University Hospital is a part of Southern and Eastern Norway Regional Health Authority.

Webmaster for research pages: Trond Olav Berg

Cookie policy

Accessibility statement (in Norwegian)